Eric Kodish, MD

216.444.3850

There is no publicly available rating for this medical professional for one of two reasons: 1) he or she does not see patients or 2) he or she sees patients but has not yet received the minimum number of Patient Satisfaction Reviews. To be eligible for display, we require a minimum of 30 surveys. This ensures that the rating is statistically reliable and a true reflection of patient satisfaction.

( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Biographical Sketch

Eric Kodish, MD is the Director of Cleveland Clinic's Center for Ethics, Humanities, and Spiritual Care. He also serves as the F. J. O'Neill Professor and Chairman of the Department of Bioethics, Executive Director of the Cleveland Fellowship in Advanced Bioethics, and Professor of Pediatrics at the Lerner College of Medicine of Case Western Reserve University.

From 1993-2004, he cared for children with cancer and blood diseases at Rainbow Babies and Children’s Hospital, where he was the founding director of the Rainbow Center for Pediatric Ethics. His areas of expertise include childhood cancer and blood diseases, pediatric ethics, end-of-life issues, and research ethics. He received the Distinguished Alumni Award from the Northeast Ohio Medical University in 2001, and was elected Chair of its Board of Trustees in 2011.

Dr. Kodish has been Principal Investigator on a series of three NCI funded multi-site studies of informed consent in childhood cancer. The American Cancer Society, Greenwall Foundation, Cleveland Foundation, the Josiah Macy Jr. Foundation and the Cancer Treatment Research Foundation have also funded his work.

He has been an active committee member and consultant at the Institute of Medicine. He served as Chair of the Bioethics Committee of the Children’s Oncology Group from 2002-2008, and was an appointed member of the Committee on Bioethics of the American Academy of Pediatrics from 1999-2005. He has also served on the Science and Medicine Advisory Committee of the United States Holocaust Memorial Museum and on the Recombinant DNA Advisory Committee (RAC) at the NIH.

He is currently a member of the Advisory Council at the National Center for Advancing Translational Sciences (NCATS) at NIH. Previously, he has been a member of the HHS Secretary’s Advisory Committee on Human Research Protections Subcommittee for Research Involving Children at the Office of Human Research Protections and the NCI’s Pediatric Central IRB. He is an elected fellow of the Hastings Center. He is the author of more than one hundred peer-reviewed publications in journals including JAMA and the New England Journal of Medicine, as well as book chapters and reviews. He is the editor of "Ethics and Research with Children: A Case-Based Approach," published by Oxford University Press (February 2005). Dr. Kodish was elected as a Fellow of the Hastings Center in 2013.

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 3/24/2015, Dr. Kodish has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Kodish receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

Biogen Idec, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.